-
1دورية أكاديمية
المؤلفون: Xiran Wang, Jianling Zhao, Zhongzheng Xiang, Xuetao Wang, Yuanyuan Zeng, Ting Luo, Xi Yan, Zhuang Zhang, Feng Wang, Lei Liu
المصدر: Frontiers in Oncology, Vol 12 (2022)
مصطلحات موضوعية: 3D-printed bolus, breast cancer, PMRT, dosimetry, radiation dermatitis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.964455/fullTest; https://doaj.org/toc/2234-943XTest
-
2دورية أكاديمية
المؤلفون: Jiaojiao Suo, Xiaorong Zhong, Ping He, Hong Zheng, Tinglun Tian, Xi Yan, Ting Luo
المصدر: Frontiers in Oncology, Vol 11 (2021)
مصطلحات موضوعية: irinotecan, metastatic breast cancer, efficacy, chemotherapy, palliative therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2021.654974/fullTest; https://doaj.org/toc/2234-943XTest
-
3دورية أكاديمية
المؤلفون: Shengchao Xu, Xi Yan, Gan Dai, Chengke Luo
المصدر: Frontiers in Oncology, Vol 11 (2021)
مصطلحات موضوعية: glioblastoma, humanized patient-derived orthotopic xenograft, immune-related adverse events, anti-CTLA4 immunotherapy, regulatory T cells, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2021.692403/fullTest; https://doaj.org/toc/2234-943XTest
-
4
المؤلفون: Gan Dai, Xi Yan, Shengchao Xu, Chengke Luo
المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)مصطلحات موضوعية: Cancer Research, CD3, medicine.medical_treatment, Population, Ipilimumab, Peripheral blood mononuclear cell, regulatory T cells, Medicine, education, RC254-282, anti-CTLA4 immunotherapy, Original Research, Tumor microenvironment, education.field_of_study, biology, business.industry, glioblastoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Oncology, Cancer research, biology.protein, immune-related adverse events, business, Tremelimumab, CD8, humanized patient-derived orthotopic xenograft, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e7c79b8a61dc2ad0b80a6d8725f2a1Test